Two Sigma Securities, LLC Novartis Ag Call Options Transaction History

Two Sigma Securities, LLC

$10.3 Billion
Q1 2024

Call Options

16 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	BUY	$95.27 - $108.47 $685,944 - $780,984	7,200 Added 94.74%	14,800 $1.43 Million
Q4 2023 Feb 14, 2024	BUY	$92.27 - $101.54 $9,227 - $10,154	100 Added 1.33%	7,600 $767,000
Q3 2023 Nov 14, 2023	BUY	$94.73 - $105.13 $9,473 - $10,513	100 Added 1.35%	7,500 $763,000
Q2 2023 Aug 14, 2023	BUY	$92.52 - $104.91 $684,648 - $776,334	7,400 New	7,400 $746,000
Q1 2022 May 16, 2022	BUY	$80.11 - $90.62 $320,440 - $362,480	4,000 New	4,000 $351,000

Q1 2021 May 17, 2021	SELL	$83.5 - $98.47 $551,100 - $649,902	-6,600 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$78.07 - $94.43 $195,174 - $236,075	-2,500 Reduced 27.47%	6,600 $623,000
Q3 2020 Nov 16, 2020	BUY	$82.14 - $91.0 $49,284 - $54,600	600 Added 7.06%	9,100 $791,000
Q2 2020 Sep 10, 2020	BUY	$80.93 - $91.1 $291,348 - $327,960	3,600 Added 73.47%	8,500 $742,000
Q1 2020 May 15, 2020	SELL	$70.67 - $99.01 $1.94 Million - $2.72 Million	-27,500 Reduced 84.88%	4,900 $404,000
Q4 2019 Feb 14, 2020	SELL	$84.35 - $95.37 $1.02 Million - $1.15 Million	-12,100 Reduced 27.19%	32,400 $3.07 Million
Q2 2019 Aug 14, 2019	SELL	$75.4 - $92.8 $377,000 - $464,000	-5,000 Reduced 10.1%	44,500 $4.06 Million
Q3 2018 Nov 14, 2018	SELL	$66.94 - $77.43 $2.73 Million - $3.16 Million	-40,800 Reduced 45.18%	49,500 $4.27 Million
Q2 2018 Aug 14, 2018	BUY	$64.91 - $73.36 $3.39 Million - $3.83 Million	52,200 Added 137.01%	90,300 $6.82 Million
Q1 2018 May 15, 2018	BUY	$70.39 - $84.15 $2.28 Million - $2.73 Million	32,400 Added 568.42%	38,100 $3.08 Million
Q4 2017 Feb 14, 2018	BUY	$72.33 - $77.64 $412,281 - $442,548	5,700	5,700 $479,000

Others Institutions Holding NVS

# of Institutions

1,350

Shares Held

140M

Call Options Held

1.15M

Put Options Held

866K

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $232B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Account